Navigation Links
PhotoMedex Covers XTRAC Laser Treatment Co-Pay for Children with Psoriasis
Date:8/4/2011

MONTGOMERYVILLE, Pa., Aug. 4, 2011 /PRNewswire/ -- PhotoMedex, Inc. (NASDAQ: PHMD), an innovator of medical devices, today launches a co-pay reimbursement offer*  to assist the families of children who suffer from psoriasis.  In honor of the National Psoriasis Awareness Month in August (and continuing through November), children, who may not have been able to afford treatments, will have their XTRAC® Excimer Laser (www.XTRACLaser.com) treatment co-pays covered by PhotoMedex.   All major insurance companies reimburse for XTRAC laser treatments, and now with co-pays covered, new hope is available for this underserved population.

For many children, the disease goes beyond the physical painful red dry patches of scaly, thickened skin and can create emotional scars. Nearly 50 percent of children with psoriasis report that they have been bullied because of their disease.  In a National Psoriasis Foundation survey of children with psoriasis, 44 percent reported that they have been bullied by their peers, and 38 percent stated the abuse was a direct result of their psoriasis.  Of those bullied, 65 percent said it caused anxiety, and nearly one-quarter had a decrease in academic performance.

About 20,000 children under the age of 10 are diagnosed with psoriasis every year in the United States. The XTRAC laser treatment provides relief from itching, redness and pain; without the negative side-effects commonly associated with other treatments, ranging from premature aging of healthy skin to the risk of malignancies and tuberculosis. The XTRAC laser is the only clinically proven, FDA-cleared, dermatology excimer laser with independent safety and quality certifications. It provides targeted phototherapy treatment for psoriasis; offering safe, effective and lasting results.

"Over 7.5 million Americans currently suffer from psoriasis and for children the emotional side-effects of the disease can outweigh the physical pain it causes," said Dr. Alan Menter with Baylor University Medical Center in Dallas, Texas.  "The XTRAC laser is an important treatment option because it is safe, quick and painless and allows children to get back to simply being a kid."

Patients who use the XTRAC often see a 75 percent or greater improvement in affected areas in six to ten brief treatment sessions, delivered twice a week. The laser is effective even on areas that are difficult to treat, such as elbows, knees and the scalp, as well as widespread psoriasis covering as much as 20 percent of body surface area.

To obtain the co-pay reimbursement offer, consumers can visit www.xtraclaser.com or call 1-800-800-4758 to connect with the XTRAC TeleCare Center to find a participating physician in their area. The rebate offer includes up to $50 reimbursement per treatment for up to 10 treatments.  Treatments must be received between August 1, 2011 and December 1, 2011. Please see full terms and conditions. PhotoMedex is offering a $100 co-pay rebate coupon for adults over the age of 18 that are not eligible for the children co-pay reimbursement offering.

PhotoMedex is also holding the "Itching to Win" contest** through August 14, 2011, in honor of National Psoriasis Awareness Month. Psoriasis patients can enter to win a full series of treatments with the XTRAC Excimer Laser by submitting a 250-word essay and photo. Six winners nationwide will be selected to receive the treatments from a local physician.

For more information about the XTRAC excimer laser, visit www.XTRACLaser.com. The website features a TeleCare Center where patients can speak directly to our highly experienced clinical specialists about the XTRAC laser therapy. These specialists can also assist those interested in making appointments with physicians experienced in providing XTRAC laser treatments.

Learn more PhotoMedex promotions on Facebook - http://www.facebook.com/pages/Xtrac-Psoriasis-Vitiligo/159178087466723

Connect with XTRAC on Twitter - www.Twitter.com/XTRACPsoriasis and on

Facebook - http://www.facebook.com/pages/Xtrac-Psoriasis-Vitiligo/159178087466723

*Terms and conditions may apply. Please read full promotion rules at www.XTRAClaser.com/childrencopay

**Terms and conditions may apply. Please read full contest rules at www.XTRAClaser.com/contest

About PhotoMedex

PhotoMedex is a leader in the development, manufacturing, and global marketing of dermatology products and techniques focused on advancing cost-effective technologies that provide patients with better outcomes and a higher quality of life. The company is uniquely positioned to research and commercialize therapies that innovatively combine both medical devices and science-based aesthetic products. Medical devices include the XTRAC®  Excimer Laser for the treatment of skin diseases like psoriasis and vitiligo and the Omnilux™ non-laser light-emitting diodes (LED) for the treatment of clinical and aesthetic dermatological conditions, including acne, photodamage, skin rejuvenation, and wound healing. Adding to these therapies, the company markets a broad range of specialty skin-care products based upon its clinically proven DNA + Copper Peptide technologies for skin heath and Copper Peptide Complexes for hair and wound care, including its NEOVA®, DNA Damage Control™, Tricomin® and Graftcyte® brands. PhotoMedex sells directly to dermatologists; plastic and cosmetic surgeons, spas; salons; and, through strategic partners, in the consumer market. In addition, the company manufactures and distributes surgical lasers and disposables to hospitals and surgery centers for procedures in urology, gynecology, orthopedics and other surgical specialties. For more information please visit www.photomedex.com.


'/>"/>
SOURCE PhotoMedex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PhotoMedexs Itching to Win Contest Offers Free Phototherapy Treatments With the XTRAC Laser to Deserving Psoriasis Patients Nationwide
2. PhotoMedex Launches New Patient-Focused XTRAC Laser Website
3. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
4. Lost and Found: L2FU Recovers 100% of Clinical Trial Patients for Recent Pivotal Study
5. John DeVincenzo, MD, at the University of Tennessee Health Science Center Discovers First Evidence that RNA-interference Drugs Reduce Human Disease
6. deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin
7. AvMed Covers H1N1 Flu Vaccine For Members
8. deCODE Discovers Four New Risk Factors for Prostate Cancer
9. CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment
10. deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
11. The Childrens Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohns Disease Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 18, 2017   Seno Medical Instruments, Inc. , ... cancer through the development of an opto-acoustic (OA/US) imaging ... as SVP of Engineering. Mr. Miller previously served ... SonoSite, with headquarters in Bothell, Washington ... 30-year career to the development of innovative medical imaging ...
(Date:1/18/2017)... LAKE, N.J. , Jan. 18, 2017 /PRNewswire/ ... Co., Ltd., announced today that it is participating ... access to non-communicable diseases (NCDs) prevention, treatment and ... Access Accelerated is the first multi-stakeholder, international ... 22 major pharmaceutical companies, including Eisai, in collaboration ...
(Date:1/18/2017)... , January 18, 2017 Ximbio, ... to share research resources, has opened its first North American ... ... marks an expansion for Ximbio following its launch in October ... Research Technology (CRT), the commercialization arm of the foundation Cancer ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... A Palm Beach doctor plans ... Train, an international charity that provides free surgery to poor children suffering from cleft ... the past I have run to support the efforts of the American Heart Association ...
(Date:1/18/2017)... ... ... The Portee Insurance Agency, a family managed firm that offers asset protection ... DC region, is inaugurating a charity event aimed at fighting heart disease in the ... #1 killer in America. However, heart disease is largely preventable, and a few minor ...
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment to quality is ... certification to ISO 13485. This certification is another way they are making constant strides ... services that they need. , The ISO 13485 Certification is a major accomplishment for ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that Mr. ... at the upcoming WCBP Conference, to be held at the Mayflower Hotel, Washington ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the World Foundation, ... the donation of cochlear implants. In February 2017, the first three children with ... chance of leading an independent life. This engagement builds on the support the ...
Breaking Medicine News(10 mins):